Literature DB >> 31754943

Predicted lean body mass, fat mass and risk of lung cancer: prospective US cohort study.

Su-Min Jeong1, Dong Hoon Lee1, Edward L Giovannucci2,3,4.   

Abstract

An inverse association between body mass index (BMI) and risk of lung cancer has been reported. However, the association of body composition such as fat mass (FM) and lean body mass (LBM) with risk of lung cancer has not been fully investigated. Using two large prospective cohort studies (Nurses' Health Study, 1986-2014; Health Professionals Follow-up Study, 1987-2012) in the United States, we included 100,985 participants who were followed for occurrence of lung cancer. Predicted FM and LBM derived from validated anthropometric prediction equations were categorized by sex-specific deciles. During an average 22.3-year follow-up, 2615 incident lung cancer cases were identified. BMI showed an inverse association with lung cancer risk. Participants in the 10th decile of predicted FM and LBM had a lower risk of lung cancer compared with those in the 1st decile, but when mutually adjusted for each other, predicted FM was not associated with lung cancer risk (adjusted hazard ratio [aHR] = 0.98, 95% confidence interval [CI] 0.72-1.35; P(trend) = 0.97) whereas predicted LBM had an inverse association (aHR = 0.73, 95% CI 0.53-1.00; P(trend) = 0.03), especially among participants who were current smokers or had smoked in the previous 10 years (aHR = 0.55, 95% CI 0.36-0.84; P(trend) = 0.008). In conclusion, BMI was inversely associated with lung cancer risk. Based on anthropometric prediction equations, low LBM rather than low FM accounted for the inverse association between BMI and lung cancer risk.

Entities:  

Keywords:  Body mass index; Fat mass; Lean body mass; Lung cancer; Smoking

Mesh:

Year:  2019        PMID: 31754943      PMCID: PMC7504685          DOI: 10.1007/s10654-019-00587-2

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  39 in total

1.  Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women.

Authors:  Dong Hoon Lee; NaNa Keum; Frank B Hu; E John Orav; Eric B Rimm; Walter C Willett; Edward L Giovannucci
Journal:  Eur J Epidemiol       Date:  2018-08-16       Impact factor: 8.082

2.  Validity of self-reported waist and hip circumferences in men and women.

Authors:  E B Rimm; M J Stampfer; G A Colditz; C G Chute; L B Litin; W C Willett
Journal:  Epidemiology       Date:  1990-11       Impact factor: 4.822

Review 3.  Importance of lean body mass in the oncologic patient.

Authors:  Susan Tsai
Journal:  Nutr Clin Pract       Date:  2012-08-16       Impact factor: 3.080

Review 4.  Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown.

Authors:  Oren Rom; Sharon Kaisari; Dror Aizenbud; Abraham Z Reznick
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  Leanness, smoking, and enhanced oxidative DNA damage.

Authors:  Tetsuya Mizoue; Hiroshi Kasai; Tatsuhiko Kubo; Shoji Tokunaga
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

6.  Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis.

Authors:  S A Khuder
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

Review 7.  Hormones of adipose tissue and their biologic role in lung cancer.

Authors:  E Ntikoudi; M Kiagia; P Boura; K N Syrigos
Journal:  Cancer Treat Rev       Date:  2013-07-16       Impact factor: 12.111

8.  Body mass index, lifetime smoking intensity and lung cancer risk.

Authors:  Mariam El-Zein; Marie-Elise Parent; Belinda Nicolau; Anita Koushik; Jack Siemiatycki; Marie-Claude Rousseau
Journal:  Int J Cancer       Date:  2013-04-25       Impact factor: 7.396

9.  Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle.

Authors:  Anne Marie Winther Petersen; Faidon Magkos; Philip Atherton; Anna Selby; Kenneth Smith; Michael J Rennie; Bente Klarlund Pedersen; Bettina Mittendorfer
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-07-03       Impact factor: 4.310

10.  Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.

Authors:  Robert Carreras-Torres; Mattias Johansson; Philip C Haycock; Kaitlin H Wade; Caroline L Relton; Richard M Martin; George Davey Smith; Demetrius Albanes; Melinda C Aldrich; Angeline Andrew; Susanne M Arnold; Heike Bickeböller; Stig E Bojesen; Hans Brunnström; Jonas Manjer; Irene Brüske; Neil E Caporaso; Chu Chen; David C Christiani; W Jay Christian; Jennifer A Doherty; Eric J Duell; John K Field; Michael P A Davies; Michael W Marcus; Gary E Goodman; Kjell Grankvist; Aage Haugen; Yun-Chul Hong; Lambertus A Kiemeney; Erik H F M van der Heijden; Peter Kraft; Mikael B Johansson; Stephen Lam; Maria Teresa Landi; Philip Lazarus; Loïc Le Marchand; Geoffrey Liu; Olle Melander; Sungshim L Park; Gad Rennert; Angela Risch; Eric B Haura; Ghislaine Scelo; David Zaridze; Anush Mukeriya; Milan Savić; Jolanta Lissowska; Beata Swiatkowska; Vladimir Janout; Ivana Holcatova; Dana Mates; Matthew B Schabath; Hongbing Shen; Adonina Tardon; M Dawn Teare; Penella Woll; Ming-Sound Tsao; Xifeng Wu; Jian-Min Yuan; Rayjean J Hung; Christopher I Amos; James McKay; Paul Brennan
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

View more
  9 in total

1.  The perils of using predicted values in place of observed covariates: an example of predicted values of body composition and mortality risk.

Authors:  Gregory Haber; Joshua Sampson; Katherine M Flegal; Barry Graubard
Journal:  Am J Clin Nutr       Date:  2021-08-02       Impact factor: 7.045

2.  The Role of Mendelian Randomization Studies in Deciphering the Effect of Obesity on Cancer.

Authors:  Zhe Fang; Mingyang Song; Dong Hoon Lee; Edward L Giovannucci
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 13.506

3.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

4.  Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus.

Authors:  Shan Gao; Hongliang Zhang; Chen Long; Zhenhua Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-26       Impact factor: 5.555

5.  The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis.

Authors:  Hui Wen; Xuefeng Lin; Daqiang Sun
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

6.  Metabolic Obesity Phenotypes and Risk of Lung Cancer: A Prospective Cohort Study of 450,482 UK Biobank Participants.

Authors:  Fang Shao; Yina Chen; Hongyang Xu; Xin Chen; Jiawei Zhou; Yaqian Wu; Yingdan Tang; Zhongtian Wang; Ruyang Zhang; Theis Lange; Hongxia Ma; Zhibin Hu; Hongbing Shen; David C Christiani; Feng Chen; Yang Zhao; Dongfang You
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

7.  Body composition and risk of gastric cancer: A population-based prospective cohort study.

Authors:  An-Ran Liu; Qiang-Sheng He; Wen-Hui Wu; Jian-Liang Du; Zi-Chong Kuo; Bin Xia; Yan Tang; Peng Yun; Eddie C Cheung; You-Zhen Tang; Yu-Long He; Chang-Hua Zhang; Jin-Qiu Yuan; Gang Sun
Journal:  Cancer Med       Date:  2021-02-23       Impact factor: 4.452

Review 8.  Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.

Authors:  Karam Khaddour; Sandra L Gomez-Perez; Nikita Jain; Jyoti D Patel; Yanis Boumber
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 5.738

9.  Body composition and risk of major gynecologic malignancies: Results from the UK Biobank prospective cohort.

Authors:  Peng Yun; Bin Xia; Xiao-Hui Tian; Ting Gong; An-Ran Liu; Jin-Qiu Yuan; Fang-Ping Li
Journal:  Cancer Med       Date:  2021-06-10       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.